Medexus Pharmaceuticals Inc. (TSX:MDP)

Canada flag Canada · Delayed Price · Currency is CAD
3.050
-0.090 (-2.87%)
At close: Mar 20, 2026
Market Cap98.28M +15.4%
Revenue (ttm)136.34M -9.2%
Net Income-372.95K
EPS-0.01
Shares Out32.22M
PE Ration/a
Forward PE7.31
Dividendn/a
Ex-Dividend Daten/a
Volume18,413
Average Volume44,972
Open3.150
Previous Close3.140
Day's Range3.050 - 3.190
52-Week Range1.960 - 3.610
Beta1.87
RSI50.21
Earnings DateJun 24, 2026

About Medexus Pharmaceuticals

Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; GRAFAPEX, an injection ... [Read more]

Sector Healthcare
Founded 2000
Employees 91
Stock Exchange Toronto Stock Exchange
Ticker Symbol MDP
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements